Cognitive status | Control | Resilient | Demented |
---|---|---|---|
Number of subjects, total N = 55 | 8 | 20 | 27 |
Mini-mental state exam | |||
Mean (SD) | 29 (0.8) | 29.1 (0.9) | 23.7 (6.6) |
Age (years) | |||
Mean (SD) | 82.6 (8.3) | 88.9 (9) | 88.1 (6.1) |
Gender | |||
Female N (%) | 4 (50%) | 11 (55%) | 13 (48%) |
Male N (%) | 4 (50%) | 9 (45%) | 14 (52%) |
ApoE allele status | |||
ApoE2 allele (%) | 0 (0%) | 2 (9%) | 2 (7%) |
ApoE3 allele (%) | 8 (100%) | 18 (82%) | 22 (79%) |
ApoE4 allele (%) | 0 (0%) | 2 (9%) | 4 (14%) |
Neuropathology ('ABC' score) | |||
A-Thal phase, range (mean) | A0-4 (1) | A0-4 (2.2) | A0-5 (2.2) |
B-Braak stage, range (mean) | 0-II (1.4) | III-IV (3.5) | III-IV (3.5) |
C-CERAD score, range (mean) | C0-2 (0.4) | C0-3 (1.4) | C0-3 (1.2) |
Vascular score | |||
Composite score, mean (SD)* | 3.8 (2) | 3 (1.9) | 5 (2.4) |
PMI (hours) | |||
Mean (SD) | 24.5 (22.8)** | 19.8 (11.8) | 17.7 (9.4)** |